Patent: 9,028,851
Summary for Patent: 9,028,851
| Title: | Hemostatic materials and devices with galvanic particulates |
| Abstract: | The present invention is directed to a hemostatic material comprising a scaffold and a galvanic particulate. The galvanic particulate comprises particles made of at least two dissimilar metals. The scaffold is preferably a biocompatible polysaccharide-based hemostatic, such as a chitosan or cellulosic based hemostatic like ORC. |
| Inventor(s): | Yi-Lan Wang, Ying Sun, Guanghui Zhang, Chunlin Yang |
| Assignee: | Ethicon Inc |
| Application Number: | US13/333,136 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,028,851
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Omrix Biopharmaceuticals Ltd | EVITHROM | thrombin, topical (human) | Solution | 125247 | August 27, 2007 | 9,028,851 | 2031-12-21 |
| Omrix Biopharmaceuticals Ltd | EVITHROM | thrombin, topical (human) | For Injection | 125247 | September 17, 2009 | 9,028,851 | 2031-12-21 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 9,028,851
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2012355476 | ⤷ Start Trial |
| Brazil | 112014015331 | ⤷ Start Trial |
| Canada | 2859784 | ⤷ Start Trial |
| China | 104244954 | ⤷ Start Trial |
| European Patent Office | 2793907 | ⤷ Start Trial |
| European Patent Office | 3064228 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
